July 20, 2026
TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs SAN DIEGO -- TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual [...]
July 20, 2026
Luba Greenwood joins Cytosurge’s Board of Directors to support the company’s next phase of commercial growth and scientific progress as Cytosurge builds the causal data foundation for AI-driven drug discovery. ZURICH, Switzerland – Cytosurge, the pioneer of Same-Cell Biology, announces the election of Luba Greenwood, J.D., to its Board of Directors, effective July 9, 2026. Greenwood is a [...]
L7 Informatics Names Ray Veeraraghavan, Ph.D., Vice President of Science and AI
July 17, 2026
Applied AI and life sciences leader joins L7's executive team to advance the L7|SYNAPSE™ Agentic AI strategy across the customer base AUSTIN, Texas -- L7 Informatics, Inc., the company behind L7|ESP®, the Enterprise Science Platform that serves as an operating system for precision science, today named Ray Veeraraghavan, Ph.D., Vice President of Science and AI. [...]
L7 Informatics Names Ray Veeraraghavan, Ph.D., Vice President of Science and AI
July 17, 2026
Applied AI and life sciences leader joins L7’s executive team to advance the L7|SYNAPSE™ Agentic AI strategy across the customer base AUSTIN, Texas — L7 Informatics, Inc., the company behind L7|ESP®, the Enterprise Science Platform that serves as an operating system for precision science, today named Ray Veeraraghavan, Ph.D., Vice President of Science and AI. Reporting to CEO [...]
July 17, 2026
SHENZHEN, China — Bettersize Instruments announces the issuance of United States Patent No. 12,680,936 B2. The patent protects a method utilizing optical path difference for the analytical calculation of particle size gradation and solid content in two-phase flows. This patented Differential Path Measurement technology is the core operational framework of the DeepSizer 300, a specialized [...]
July 16, 2026
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX® platform across India. Under the agreement, ILS will distribute [...]
July 16, 2026
On its 20th anniversary, DECTRIS extends its mission further, from detecting the invisible to transforming it into the understandable with a platform designed to connect data, analyses, compute, and scientific context into one home for modern research. Science has changed Over the past two decades, science has become fundamentally more complex and computational. Experiments generate [...]
July 16, 2026
New Juno Bio lab infrastructure marks a major step in scaling provider-led care and advancing precision vaginal microbiome testing OAKLAND, Calif. -- Juno Bio, a women's health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women's [...]
Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network
July 16, 2026
Researchers across Asia-Pacific gain a new option for high-quality single cell sequencing through Garvan’s Evercode WT services SEATTLE — Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider [...]
Illumina expands Billion Cell Atlas program with new AI drug developers
July 16, 2026
Partners will use unprecedented data scale to advance more precise medicines to approval SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer Formation Bio. As leaders in AI-driven drug discovery, design, and development, alliance members will use the unprecedented [...]

